Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2020 1
2021 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.
Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, Flaten GE, Fotaki N, Griffin BT, Jannin V, Keemink J, Kesisoglou F, Koziolek M, Kuentz M, Mackie A, Meléndez-Martínez AJ, McAllister M, Müllertz A, O'Driscoll CM, Parrott N, Paszkowska J, Pavek P, Porter CJH, Reppas C, Stillhart C, Sugano K, Toader E, Valentová K, Vertzoni M, De Wildt SN, Wilson CG, Augustijns P. Vinarov Z, et al. Among authors: paszkowska j. Adv Drug Deliv Rev. 2021 Apr;171:289-331. doi: 10.1016/j.addr.2021.02.001. Epub 2021 Feb 18. Adv Drug Deliv Rev. 2021. PMID: 33610694 Free article. Review.
A novel open source tool for ELISA result analysis.
Danielak D, Banach G, Walaszczyk J, Romański M, Bawiec M, Paszkowska J, Zielińska M, Sczodrok J, Wiater M, Hoc D, Kołodziej B, Garbacz G. Danielak D, et al. Among authors: paszkowska j. J Pharm Biomed Anal. 2020 Sep 10;189:113415. doi: 10.1016/j.jpba.2020.113415. Epub 2020 Jun 20. J Pharm Biomed Anal. 2020. PMID: 32574997 Free article.
A Rational Approach to Predicting Immediate Release Formulation Behavior in Multiple Gastric Motility Patterns: A Combination of a Biorelevant Apparatus, Design of Experiments, and Machine Learning.
Staniszewska M, Romański M, Polak S, Garbacz G, Dobosz J, Myslitska D, Romanova S, Paszkowska J, Danielak D. Staniszewska M, et al. Among authors: paszkowska j. Pharmaceutics. 2023 Jul 31;15(8):2056. doi: 10.3390/pharmaceutics15082056. Pharmaceutics. 2023. PMID: 37631270 Free PMC article.
Application of a novel PhysioCell apparatus for biopredictive dissolution tests of oral immediate release formulations - A case study workflow for in vitro-in vivo predictions.
Romański M, Staniszewska M, Paszkowska J, Dobosz J, Romanova S, Pieczuro J, Kątny M, Roznerska D, Szczepański J, Schraube M, Renn-Hojan M, Puk E, Hrem O, Garbacz G, Danielak D. Romański M, et al. Among authors: paszkowska j. Int J Pharm. 2023 Jun 25;641:123061. doi: 10.1016/j.ijpharm.2023.123061. Epub 2023 May 19. Int J Pharm. 2023. PMID: 37211237
Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drug.
Danielak D, Paszkowska J, Staniszewska M, Garbacz G, Terlecka A, Kubiak B, Romański M. Danielak D, et al. Among authors: paszkowska j. Eur J Pharm Biopharm. 2023 May;186:132-143. doi: 10.1016/j.ejpb.2023.03.014. Epub 2023 Apr 2. Eur J Pharm Biopharm. 2023. PMID: 37015321 Free article.
Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial.
Juszczyk E, Kisło K, Żero P, Tratkiewicz E, Wieczorek M, Paszkowska J, Banach G, Wiater M, Hoc D, Garbacz G, Sczodrok J, Danielak D. Juszczyk E, et al. Among authors: paszkowska j. Pharmaceutics. 2021 May 28;13(6):804. doi: 10.3390/pharmaceutics13060804. Pharmaceutics. 2021. PMID: 34071286 Free PMC article.
An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics - A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients.
Romański M, Giebułtowicz J, Gniazdowska E, Piotrowski R, Żuk A, Kułakowski P, Paszkowska J, Myslitska D, Sczodrok J, Garbacz G, Danielak D. Romański M, et al. Among authors: paszkowska j. Int J Pharm. 2024 Jan 5;649:123626. doi: 10.1016/j.ijpharm.2023.123626. Epub 2023 Nov 23. Int J Pharm. 2024. PMID: 38000647
13 results